Moneycontrol
HomeNewsBusinessSome airlines offer India-UK flights at Rs 19,000-Rs 34,000 in mid-Sept vs current Rs 1-1.5 lakh
Trending Topics

Some airlines offer India-UK flights at Rs 19,000-Rs 34,000 in mid-Sept vs current Rs 1-1.5 lakh

Airfares between India and UK are likely to fall towards normal levels are more flights are being added on the route, but Etihad, Turkish Airlines and Emirates are already offering much cheaper tickets for mid-September

August 12, 2021 / 19:47 IST
Story continues below Advertisement
(Representative Image: Reuters)

Airfares between India and UK have soared to the range of Rs 1.2 lakh to 1.5 lakh for flights in the rest of August but for mid-September, Etihad, Turkish Airlines and Emirates charging much lower rates -- between Rs 20,000 and Rs 35,000.

Fares shot up last week because of the sudden spike in demand after the UK decided to move India from its “red list” to the “amber” category, opening up the possibility of Indians to travel to the country without the mandatory 10-day hotel quarantine.

Story continues below Advertisement

Also Read: Explained | Why India-UK airfares are high and could remain so

The rush led to air fares shooting up from about Rs 50,000-Rs 70,000 before August 8 to between Rs 1,18,344 and Rs 1,48,355 for August, data collected by Moneycontrol from Air India, Vistara Airlines, Yatra.com, and EaseMyTrip.com showed.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show